Egepol Hastanesi (EGEPO) Fundamental Analysis
This page summarises the financial statements and the KapAI scorecard of Egepol Hastanesi (EGEPO) in the İlaç ve Sağlık sector for the 2026/6 period. Figures are compiled from the company’s reported balance sheet and income statement, in millions of Turkish lira.
Company Information
- Company: Egepol Hastanesi
- Ticker: EGEPO
- Sector: İlaç ve Sağlık
- Latest reporting period: 2026/6
KapAI Scorecard
Overall score: 3.9 / 5
- Profitability: 3.4 / 5
- Liquidity: 4.8 / 5
- Leverage: 3.6 / 5
- Efficiency: 4.0 / 5
Summary Income Statement (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Revenue | 957 | 783 | +22.2% |
| Gross Profit | 137 | 148 | -7.3% |
| Operating Profit | 51 | 23 | +119.8% |
| EBITDA | 0 | 0 | — |
| Net Monetary Position Gains | -26 | -25 | -6.0% |
| Net Profit for the Period | -62 | -3 | -2,276.9% |
Summary Balance Sheet (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Current Assets | 537 | 264 | +103.1% |
| Non-Current Assets | 2,201 | 1,696 | +29.8% |
| Total Assets | 2,738 | 1,961 | +39.6% |
| Current Liabilities | 290 | 180 | +61.2% |
| Non-Current Liabilities | 287 | 160 | +78.8% |
| Total Liabilities | 577 | 340 | +69.5% |